Patents by Inventor Meghan Thorne MILLER

Meghan Thorne MILLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230287035
    Abstract: The present invention provides a pharmaceutical composition comprising an effective dosage of at least one anti miR-134 oligonucleotide for administration to a mammal suffering from a disease wherein lowering of the activity of miR-134 is beneficial, wherein single administration of the pharmaceutical composition time interval between each administration is at least 50 days and methods using such composition.
    Type: Application
    Filed: December 13, 2022
    Publication date: September 14, 2023
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: David C. HENSHALL, Cristina A. RESCHKE, Meghan Thorne MILLER
  • Publication number: 20210220387
    Abstract: The present invention provides a pharmaceutical composition comprising an effective dosage of at least one anti miR-134 oligonucleotide for administration to a mammal suffering from a disease wherein lowering of the activity of miR-134 is beneficial, wherein single administration of the pharmaceutical composition time interval between each administration is at least 50 days and methods using such composition.
    Type: Application
    Filed: May 15, 2019
    Publication date: July 22, 2021
    Applicant: Hoffmann-La Roche, Inc.
    Inventors: David C. HENSHALL, Cristina A. RESCHKE, Meghan Thorne MILLER